Proactive Versus Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s Disease: Is the Juice Worth the Squeeze?

Proactive Versus Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s Disease: Is the Juice Worth the Squeeze?

Inflamm Bowel Dis. 2019 Jun 10;:

Authors: Franco DL, Click B

PMID: 31184363 [PubMed – as supplied by publisher]

PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/31184363?dopt=Abstract